Assorted News from the Last Week: New estimates that quantify country-specific and worldwide incidence, mortality, and survival for childhood cancers point to worldwide inequity and

Assorted News from the Last Week: CAC2 Member LifeArc releases the paediatric therapeutic development workshop priorities for osteosarcoma, with CAC2 contributing authors Ann Graham and

Assorted News from the Last Week: Race and ethnicity and overall survival in pediatric acute myeloid leukemia Current perspectives on molecular pathogenesis, surveillance strategies, clinical

Assorted News from the Last Week: CAC2 Blog Post: “How Kentucky Built a $50 Million Pediatric Cancer Research Fund, and What Other States Can Learn

Assorted News from the Last Week: Diagnosis. Relapse. Clinical trial. Immunotherapy. Remission. Those words are all true. But they are not Emily Whitehead’s whole story. CAC2

Assorted News from the Last Week: This Lancet Child & Adolescent Health article with contributions by CAC2 Members Nicole Scobie and Vickie Buenger argues for

Assorted News from the Last Week: NYTimes essay: “For families facing a deadly brain cancer, scientific progress can’t come soon enough” (ungated!)  Families face lasting

Assorted News from the Last Week: Congressman Michael McCaul with Childhood Cancer Caucus co-chairs Ami Bera, M.D. (D-Calif.) and Mike Kelly (R-Penn.)introduced the Accelerating Innovation

Assorted News from the Last Week: Researchers advance fertility options for childhood cancer survivors. Pediatric cancer survival has improved substantially in recent decades; however, these

Assorted News from the Last Week: CAC2 Member Regina Karchner (Childhood Brain Cancer Foundation) focuses the light on survivorship as we end Survivorship Month with